Search
for
Sort by
Research 31–60 of 138
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- The Role of Micronutrients in Alopecia Areata: A Review
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Androgens in women
- Polycystic ovary syndrome: A review for dermatologists
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- Contraceptive use in acne
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- YouTube and the implementation and discontinuation of the oral contraceptive pill: A mixed-method content analysis
- Endocrine disorders and hormonal therapy for adolescent acne
- PCOS and Obesity: Contraception Challenges
- Ottawa, Ontario, Canada, February 13–16, 2013
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Diagnostik und Therapie der kutanen Androgenisierung im klimakterischen Übergang sowie in der Peri- und Postmenopause: Hirsutismus und Alopezie
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Global Landscapes of Human Phenotypic Variation in Inherited Traits
- The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified?
- BRIDGING THE GAP IN ACNE MANAGEMENT: A NARRATIVE REVIEW OF CURRENT THERAPIES AND THE EMERGENCE OF CLASCOTERONE
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- The Role of Janus Kinase Inhibitors in Dermatology
- Is There An Association Between 25(OH)D Serum Levels and Vitamin D Status with The Severity of Androgenetic Alopecia Severity in Men?
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)